InsiderTrades

Form 4 for CARL CARLSMED, INC.

Accepted 2025-07-24 00:00:00 ET · period of report 2025-07-22 · accession 0000950170-25-098528 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2025-07-24 2025-07-24 CARL YOUNG PHILIP M Dir P - Purchase $15.00 +60.0K 53.3K New +$900.0K
DI 2025-07-24 2025-07-24 CARL YOUNG PHILIP M Dir C - Cnv Deriv — +28.9K 28.9K New —
D 2025-07-24 2025-07-22 CARL YOUNG PHILIP M Dir A - Grant $0.00 +17.3K 17.3K New $0
DI 2025-07-24 2025-07-24 CARL YOUNG PHILIP M Dir C - Cnv Deriv — -28.9K 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-07-24 P A 6,666 $15.00 35,566 I See Footnotes — — (F6) Includes 6,666 shares of the Issuer's common stock purchased by PMY Partners L.P. in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering. (F7) (7) Includes (i) 6,666 shares of the Issuer's common stock purchased by PMY Partners L.P. in the Issuer's initial public offering at the public offering price of $15.00 per share, and (ii) 28,900 shares of common stock issued to PMY Partners L.P. upon the conversion of outstanding preferred stock on a 1-to-1 basis, immediately prior to the closing of the Issuer's public offering. (F10) Reporting Person is a trustee of the Trust and has voting and dispositive power over the stock held by the Trust. (F9) Stock held by the Trust.
2 Common Common Stock 2025-07-24 C A 28,900 — 28,900 I See Footnotes — — (F3) These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date. (F4) Stock held by PMY Partners LP. (F5) Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.
3 Common Common Stock 2025-07-22 A A 17,333 $0.00 17,333 D See Footnotes — — (F1) Constitute an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in equal annual installments over three years. (F2) Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock. (F4) Stock held by PMY Partners LP. (F5) Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.
4 Common Common Stock 2025-07-24 P A 53,333 $15.00 53,333 I — — (F8) Includes 53,333 shares of the Issuer's common stock purchased by the Young Family Trust dtd 04/13/1998 Nancy Halsey Young & Philip Young, Trustees (the "Trust") in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering.
5 Derivative Series B Preferred Stock 2025-07-24 C D 28,900 — 0 I See Footnotes — · — to — 28,900 Common Stock (F3) These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date. (F4) Stock held by PMY Partners LP. (F5) Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.